OR02-3 SLAMF-1 mediates Hepatocyte Death in Non-Alcoholic Fatty Liver Disease and is Plasma values correlates with the Severity of the Disease in Human

The signaling lymphocytic activation molecule 1 (SLAMF1) exerts a role in regulating the immune response to some viruses and parasite infections. In the present study, we identified SLAMF1 as a potential therapeutic target and biomarker for Non-Alcoholic Fatty Liver Disease (NASH) in humans. We foun...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexander, Jonathan S, Burgos-Ramos, Emma, Chapa-Rodriguez, Adrian, Cohen, Ari, Cruz-Topete, Diana, Dhaibar, Hemangini, Gomez-Torres, Oscar, Kamberov, Lilly, Khanna, Pranshu, Nunez, Kelly, Orr, Wayne A, Ron, Orem, Samant, Hrishikesh, Thevenot, Paul, Yurgadul, Arif, Amatya, Shripa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Cardiovascular Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624722/
http://dx.doi.org/10.1210/jendso/bvac150.509

Ejemplares similares

Ejemplares similares